1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Marx, U.C. Roesch, P. Adermann, K. Bayer, P. Forssmann, W.-G. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochem.Biophys.Res.Commun. BBRCA9 0146 0006-291X 267 213 220 10.1006/bbrc.1999.1958 10623601 Solution structures of human parathyroid hormone fragments hPTH(1-34) and hPTH(1-39) and bovine parathyroid hormone fragment bPTH(1-37). 2000 10.2210/pdb1bwx/pdb pdb_00001bwx 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 4537.273 PARATHYROID HORMONE RESIDUES 1-39 1 man polymer no no SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNFVALGA SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNFVALGA A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo sample 9606 Homo sapiens database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 2000-01-14 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-02-16 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site Y BNL 1998-09-29 REL REL THE DISTANCE RESTRAINTS USED FOR STRUCTURE CALCULATION WERE OBTAINED FROM TWO-DIMENSIONAL HOMONUCLEAR 1H- NOESY SPECTRA. ENERGY, AGREEMENT WITH EXPERIMENTAL DATA 30 10 NOESY COSY TOCSY 320 mM 5.8 1 atm 298 K THE STRUCTURE CALCULATION FOLLOWED STANDARD PROCEDURES EMPLOYING A HYBRID DISTANCE GEOMETRY MOLECULAR DYNAMICS APPROACH WITH SIMULATED ANNEALING REFINEMENT AND SUBSEQUENT ENERGY MINIMIZATION. FOR THE REFINEMENT THE DIELECTRIC CONSTANT WAS CHANGED TO 4. STRUCTURE PARAMETERS WERE EXTRACTED FROM THE STANDARD FILES PARALLHDG.PRO AND TOPALLHDG.PRO OF X-PLOR 3.1. IN EACH ROUND OF THE STRUCTURE CALCULATION 30 STRUCTURES WERE CALCULATED. OF THE 30 STRUCTURES RESULTING FROM THE FINAL ROUND OF STRUCTURE CALCULATION, THOSE 10 STRUCTURES THAT SHOWED THE LOWEST TOTAL ENERGY VALUES WERE SELECTED FOR FURTHER CHARACTERIZATION. SIMULATED ANNEALING, RESTRAINED MOLECULAR DYNAMICS 10% D2O/90% H2O BRUNGER refinement X-PLOR 3.1 structure solution NDEE structure solution X-PLOR 600 Bruker AMX600 SER 1 n 1 SER 1 A VAL 2 n 2 VAL 2 A SER 3 n 3 SER 3 A GLU 4 n 4 GLU 4 A ILE 5 n 5 ILE 5 A GLN 6 n 6 GLN 6 A LEU 7 n 7 LEU 7 A MET 8 n 8 MET 8 A HIS 9 n 9 HIS 9 A ASN 10 n 10 ASN 10 A LEU 11 n 11 LEU 11 A GLY 12 n 12 GLY 12 A LYS 13 n 13 LYS 13 A HIS 14 n 14 HIS 14 A LEU 15 n 15 LEU 15 A ASN 16 n 16 ASN 16 A SER 17 n 17 SER 17 A MET 18 n 18 MET 18 A GLU 19 n 19 GLU 19 A ARG 20 n 20 ARG 20 A VAL 21 n 21 VAL 21 A GLU 22 n 22 GLU 22 A TRP 23 n 23 TRP 23 A LEU 24 n 24 LEU 24 A ARG 25 n 25 ARG 25 A LYS 26 n 26 LYS 26 A LYS 27 n 27 LYS 27 A LEU 28 n 28 LEU 28 A GLN 29 n 29 GLN 29 A ASP 30 n 30 ASP 30 A VAL 31 n 31 VAL 31 A HIS 32 n 32 HIS 32 A ASN 33 n 33 ASN 33 A PHE 34 n 34 PHE 34 A VAL 35 n 35 VAL 35 A ALA 36 n 36 ALA 36 A LEU 37 n 37 LEU 37 A GLY 38 n 38 GLY 38 A ALA 39 n 39 ALA 39 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A ARG 20 0.307 SIDE CHAIN 1 A ARG 25 0.313 SIDE CHAIN 2 A ARG 20 0.318 SIDE CHAIN 2 A ARG 25 0.308 SIDE CHAIN 3 A ARG 20 0.316 SIDE CHAIN 3 A ARG 25 0.314 SIDE CHAIN 4 A ARG 20 0.317 SIDE CHAIN 4 A ARG 25 0.317 SIDE CHAIN 5 A ARG 20 0.315 SIDE CHAIN 5 A ARG 25 0.315 SIDE CHAIN 6 A ARG 20 0.315 SIDE CHAIN 6 A ARG 25 0.294 SIDE CHAIN 7 A ARG 20 0.311 SIDE CHAIN 7 A ARG 25 0.317 SIDE CHAIN 8 A ARG 20 0.314 SIDE CHAIN 8 A ARG 25 0.314 SIDE CHAIN 9 A ARG 20 0.293 SIDE CHAIN 9 A ARG 25 0.307 SIDE CHAIN 10 A ARG 20 0.316 SIDE CHAIN 10 A ARG 25 0.279 SIDE CHAIN 1 A LEU 11 33.56 58.63 1 A LEU 15 57.22 86.60 1 A ASN 16 -142.16 -63.57 1 A SER 17 -107.96 -88.10 1 A ASN 33 -103.51 44.28 2 A SER 3 -135.86 -54.84 2 A GLN 6 -141.20 -45.06 2 A ASN 10 -103.00 49.08 2 A LYS 13 73.18 -67.13 2 A ASN 16 -158.16 -63.55 2 A SER 17 -143.22 -63.48 2 A ARG 20 -99.29 32.32 2 A VAL 21 -121.95 -54.57 2 A LYS 26 -108.41 44.68 2 A LYS 27 -145.42 -56.22 2 A VAL 31 -121.42 -89.11 3 A VAL 2 74.58 -55.46 3 A ASN 10 -92.04 51.42 3 A LEU 11 -176.67 -56.07 3 A LYS 13 -61.74 97.29 3 A MET 18 74.69 -65.58 3 A ASN 33 -111.01 58.87 3 A ALA 36 74.62 -63.44 3 A LEU 37 -138.87 -44.25 4 A ILE 5 82.22 -56.60 4 A GLN 6 65.13 -66.53 4 A LYS 13 -122.42 -57.18 4 A LEU 15 61.54 78.26 4 A ASN 16 -121.23 -62.93 4 A SER 17 -136.43 -67.46 4 A ALA 36 68.69 164.15 5 A GLU 4 -140.77 39.11 5 A ASN 10 -94.11 45.65 5 A LEU 11 -150.96 72.26 5 A HIS 14 -107.72 48.02 5 A LEU 15 -164.83 83.08 5 A ASN 16 -129.52 -60.43 5 A SER 17 -131.34 -72.47 5 A ASN 33 -88.36 48.84 5 A VAL 35 -123.25 -63.27 6 A VAL 2 -143.44 -53.19 6 A SER 3 -162.17 75.15 6 A ILE 5 73.63 -63.17 6 A LEU 11 -153.12 73.98 6 A LYS 13 69.20 -75.68 6 A SER 17 -149.66 -74.84 6 A ASN 33 -91.97 56.40 6 A PHE 34 -164.26 -57.70 6 A VAL 35 -136.26 -53.69 6 A ALA 36 -179.58 -65.86 7 A VAL 2 -164.53 -47.57 7 A GLN 6 61.74 -77.43 7 A LEU 11 -97.82 52.84 7 A LYS 13 55.42 -95.35 7 A HIS 14 -140.69 10.54 7 A SER 17 -156.52 -59.05 7 A VAL 35 -104.53 53.86 8 A SER 3 -90.86 -62.16 8 A GLU 4 175.67 -50.72 8 A LYS 13 67.73 -80.32 8 A HIS 14 -163.79 100.74 8 A LEU 15 -134.50 -157.41 8 A ASN 16 -175.17 115.05 8 A SER 17 46.12 -102.95 8 A VAL 21 -146.47 -51.26 8 A ASN 33 -110.77 65.68 8 A VAL 35 -132.16 -63.88 8 A ALA 36 -159.56 -59.94 9 A GLU 4 -171.43 -34.12 9 A ILE 5 81.61 -49.20 9 A ASN 10 -159.44 -60.30 9 A SER 17 60.64 -79.08 9 A GLN 29 -92.87 33.92 9 A ASN 33 77.10 -58.80 9 A VAL 35 -157.39 43.97 9 A LEU 37 63.25 -83.01 10 A SER 3 69.74 166.60 10 A LYS 13 70.89 -71.92 10 A HIS 14 -114.76 52.23 10 A LEU 15 -132.50 -61.36 10 A ASN 16 61.69 92.87 10 A SER 17 81.16 -48.15 10 A VAL 21 -157.21 -59.17 10 A ALA 36 -135.72 -58.05 10 A LEU 37 -149.91 -62.33 model building X-PLOR 3.1 refinement X-PLOR 3.1 phasing X-PLOR 3.1 THE SOLUTION STRUCTURE OF HUMAN PARATHYROID HORMONE FRAGMENT 1-39, NMR, 10 STRUCTURES 1 Y N A ILE 5 A ILE 5 HELX_P A ASN 10 A ASN 10 1 1 6 A MET 18 A MET 18 HELX_P A HIS 32 A HIS 32 1 2 15 PEPTIDE HORMONE PEPTIDE HORMONE, SOLUTION STRUCTURE, HUMAN PARATHYROID HORMONE PTHY_HUMAN UNP 1 1 P01270 MIPAKDMAKVMIVMLAICFLTKSDGKSVKKRSVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNFVALGAPLAPRDAGSQ RPRKKEDNVLVESHEKSLGEADKADVNVLTKAKSQ 32 70 1BWX 1 39 P01270 A 1 1 39 1 P 1